Absence of Relationship between Mitochondrial DNA Haplogroups and Cisplatin-Induced Hearing Loss

Table 3

Distribution of hearing loss over haplogroups (%) ().

Haplogroup	Hearing loss		Total
	No	Yes
H	65.71%	34.29%	48.61%
K	45.45%	54.55%	15.28%
U	66.67%	33.33%	8.33%
V	55.56%	44.44%	12.5%
Others	54.55%	45.45%	15.28%
Total	59.72%	40.28%	100%